Ray has over fifteen years of experience in the industry working for both pharmaceutical and CRO/CMO companies. As a member of the Syner-G Executive Leadership team, he leads the CMC Development and Project Management business unit. His team is responsible for providing scientific solutions for drug development programs including identifying and managing CRO/CMO/CDMOs for Syner-G’s clients to support drug substance, drug product, and analytical development activities in biologics, small molecules, and peptides.